Olinciguat

DRUG2 trials

Sponsors

Cyclerion Therapeutics

Conditions

AchalasiaHealthy

Phase 1

A Trial to Evaluate the Effect of Itraconazole (ITZ), a CYP3A4 Inhibitor, on the Pharmacokinetics of the Soluble Guanylate Cyclase Stimulator, Olinciguat (IW-1701), in Healthy Volunteers

CompletedNCT03892499

Cyclerion TherapeuticsHealthy

Start: 2019-05-03End: 2019-07-03Updated: 2019-07-15

Phase 2

Study of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Patients With Type I or II Achalasia

TerminatedNCT02931565

Cyclerion TherapeuticsAchalasia

Start: 2017-04-06End: 2018-05-01Updated: 2021-05-04